BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14729624)

  • 41. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach.
    Cui G; Koh TJ; Chen D; Zhao CM; Takaishi S; Dockray GJ; Varro A; Rogers AB; Fox JG; Wang TC
    Cancer Res; 2004 Nov; 64(22):8160-6. PubMed ID: 15548680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence.
    Smith AM; Watson SA
    Gut; 2000 Dec; 47(6):820-4. PubMed ID: 11076881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth-promoting effects of glycine-extended progastrin.
    Seva C; Dickinson CJ; Yamada T
    Science; 1994 Jul; 265(5170):410-2. PubMed ID: 8023165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting lung cancer prognosis using machine learning.
    Burki TK
    Lancet Oncol; 2016 Oct; 17(10):e421. PubMed ID: 27569440
    [No Abstract]   [Full Text] [Related]  

  • 45. Metabolism and influence of glycine-extended gastrin on gastric acid secretion in man.
    Palnaes Hansen C; Stadil F; Rehfeld JF
    Digestion; 1996; 57(1):22-9. PubMed ID: 8626044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.
    Sepesi B; Nelson DB; Mitchell KG; Gibbons DL; Heymach JV; Vaporciyan AA; Swisher SG; Roszik J
    Ann Thorac Surg; 2018 Jun; 105(6):1621-1626. PubMed ID: 29510096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
    Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycine-extended progastrin processing intermediates: accumulation and cosecretion with gastrin.
    Sugano K; Park J; Dobbins WO; Yamada T
    Am J Physiol; 1987 Oct; 253(4 Pt 1):G502-7. PubMed ID: 2889366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of CD151 overexpression in non-small cell lung cancer.
    Kwon MJ; Seo J; Kim YJ; Kwon MJ; Choi JY; Kim TE; Lee DH; Park S; Shin YK; Han J; Choi YL
    Lung Cancer; 2013 Jul; 81(1):109-16. PubMed ID: 23570797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
    Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
    Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CCK-B/gastrin receptors in human colorectal cancer.
    Schmitz F; Otte JM; Stechele HU; Reimann B; Banasiewicz T; Fölsch UR; Schmidt WE; Herzig KH
    Eur J Clin Invest; 2001 Sep; 31(9):812-20. PubMed ID: 11589724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.
    Pruitt SL; Laccetti AL; Xuan L; Halm EA; Gerber DE
    Br J Cancer; 2017 Mar; 116(6):717-725. PubMed ID: 28196065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma.
    Caplin M; Khan K; Savage K; Rode J; Varro A; Michaeli D; Grimes S; Brett B; Pounder R; Dhillon A
    J Hepatol; 1999 Mar; 30(3):519-26. PubMed ID: 10190738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of posttranslational processing of gastrin precursor in dogs.
    Varro A; Nemeth J; Bridson J; Lonovics J; Dockray GJ
    Am J Physiol; 1990 Jun; 258(6 Pt 1):G904-9. PubMed ID: 2360636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of metallothionein expression in non-small cell lung carcinomas.
    Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues.
    Del Valle J; Sugano K; Yamada T
    Gastroenterology; 1987 Jun; 92(6):1908-12. PubMed ID: 3569767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrin interferes with the differentiation of gastric pit cells and parietal cells.
    Nakajima T; Konda Y; Izumi Y; Kanai M; Takeuchi T; Chiba T
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():3-9. PubMed ID: 11966518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastrin in non-neoplastic pancreatic tissue from patients with and without gastrinomas.
    Bardram L
    Scand J Gastroenterol; 1990 Sep; 25(9):935-43. PubMed ID: 2218398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W; Jiang WY; Chen WS; Sun W; Fu XN
    Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.